{"meshTags":["Adult","Aged","Antineoplastic Agents","Antineoplastic Combined Chemotherapy Protocols","Bone Neoplasms","Breast Neoplasms","Female","Furans","Humans","Ketones","Liver Neoplasms","Lymphatic Metastasis","Middle Aged","Retrospective Studies"],"meshMinor":["Adult","Aged","Antineoplastic Agents","Antineoplastic Combined Chemotherapy Protocols","Bone Neoplasms","Breast Neoplasms","Female","Furans","Humans","Ketones","Liver Neoplasms","Lymphatic Metastasis","Middle Aged","Retrospective Studies"],"publicationTypes":["Letter"],"title":"Treatment with eribulin (halaven) in heavily pre-treated patients with metastatic breast cancer.","pubmedId":"24844919"}